메뉴 건너뛰기




Volumn 9, Issue 11, 2013, Pages 1609-1622

Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis

Author keywords

bone metastasis; epithelial cells; epithelial mesenchymal transition; immunoregulation; migration; osteoclastogenesis; RANKL

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CARCINOGEN; CYTOKINE; DENOSUMAB; HORMONE; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; ZOLEDRONIC ACID;

EID: 84887294582     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.115     Document Type: Review
Times cited : (19)

References (123)
  • 1
    • 0030714605 scopus 로고    scopus 로고
    • A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
    • Anderson DM, Maraskovsky E, Billingsley WL et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390(6656), 175-179 (1997).
    • (1997) Nature , vol.390 , Issue.6656 , pp. 175-179
    • Anderson, D.M.1    Maraskovsky, E.2    Billingsley, W.L.3
  • 2
    • 14444272043 scopus 로고    scopus 로고
    • TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
    • Wong BR, Rho J, Arron J et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272(40), 25190-25194 (1997).
    • (1997) J. Biol. Chem. , vol.272 , Issue.40 , pp. 25190-25194
    • Wong, B.R.1    Rho, J.2    Arron, J.3
  • 3
    • 84880920106 scopus 로고    scopus 로고
    • RANKL-RANK interaction in immune regulatory systems
    • Akiyama T, Shinzawa M, Akiyama N. RANKL-RANK interaction in immune regulatory systems. World J. Orthop. 3(9), 142-150 (2012).
    • (2012) World J. Orthop. , vol.3 , Issue.9 , pp. 142-150
    • Akiyama, T.1    Shinzawa, M.2    Akiyama, N.3
  • 4
    • 0031005576 scopus 로고    scopus 로고
    • Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
    • Simonet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2), 309-319 (1997).
    • (1997) Cell , vol.89 , Issue.2 , pp. 309-319
    • Simonet, W.S.1    Lacey, D.L.2    Dunstan, C.R.3
  • 5
    • 0009660825 scopus 로고    scopus 로고
    • Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
    • Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139(3), 1329-1337 (1998).
    • (1998) Endocrinology , vol.139 , Issue.3 , pp. 1329-1337
    • Yasuda, H.1    Shima, N.2    Nakagawa, N.3
  • 6
    • 0033532191 scopus 로고    scopus 로고
    • Evidence for a role of a tumor necrosis factor-a (TNF-a)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival
    • Lum L, Wong BR, Josien R et al. Evidence for a role of a tumor necrosis factor-a (TNF-a)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J. Biol. Chem. 274(19), 13613-13618 (1999).
    • (1999) J. Biol. Chem. , vol.274 , Issue.19 , pp. 13613-13618
    • Lum, L.1    Wong, B.R.2    Josien, R.3
  • 7
    • 34548647431 scopus 로고    scopus 로고
    • RANKL RANK osteoprotegerin: Key partners of osteoimmunology and vascular diseases
    • Baud'huin M, Lamoureux F, Duplomb L, Redini F, Heymann D. RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases. Cell. Mol. Life Sci. 64(18), 2334-2350 (2007).
    • (2007) Cell. Mol. Life Sci. , vol.64 , Issue.18 , pp. 2334-2350
    • Baud'Huin, M.1    Lamoureux, F.2    Duplomb, L.3    Redini, F.4    Heymann, D.5
  • 8
    • 84860364397 scopus 로고    scopus 로고
    • Bench to bedside: Elucidation of the OPG-RANK-RANKL pathway and the development of denosumab
    • Lacey DL, Boyle WJ, Simonet WS et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat. Rev. Drug Discov. 11(5), 401-419 (2012).
    • (2012) Nat. Rev. Drug Discov. , vol.11 , Issue.5 , pp. 401-419
    • Lacey, D.L.1    Boyle, W.J.2    Simonet, W.S.3
  • 10
    • 0033599563 scopus 로고    scopus 로고
    • A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/ RANKL, regulates osteoclast differentiation and function
    • Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256(3), 449-455 (1999).
    • (1999) Biochem. Biophys. Res. Commun. , vol.256 , Issue.3 , pp. 449-455
    • Takahashi, N.1    Udagawa, N.2    Suda, T.3
  • 11
    • 0033168518 scopus 로고    scopus 로고
    • Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
    • Jimi E, Akiyama S, Tsurukai T et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163(1), 434-442 (1999).
    • (1999) J. Immunol. , vol.163 , Issue.1 , pp. 434-442
    • Jimi, E.1    Akiyama, S.2    Tsurukai, T.3
  • 12
    • 0033611467 scopus 로고    scopus 로고
    • OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
    • Kong YY, Yoshida H, Sarosi I et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397(6717), 315-323 (1999).
    • (1999) Nature , vol.397 , Issue.6717 , pp. 315-323
    • Kong, Y.Y.1    Yoshida, H.2    Sarosi, I.3
  • 13
    • 0033568341 scopus 로고    scopus 로고
    • RANK is essential for osteoclast and lymph node development
    • Dougall WC, Glaccum M, Charrier K et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13(18), 2412-2424 (1999).
    • (1999) Genes Dev. , vol.13 , Issue.18 , pp. 2412-2424
    • Dougall, W.C.1    Glaccum, M.2    Charrier, K.3
  • 14
    • 80053938104 scopus 로고    scopus 로고
    • Evidence for osteocyte regulation of bone homeostasis through RANKL expression
    • Nakashima T, Hayashi M, Fukunaga T et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17(10), 1231-1234 (2011).
    • (2011) Nat. Med. , vol.17 , Issue.10 , pp. 1231-1234
    • Nakashima, T.1    Hayashi, M.2    Fukunaga, T.3
  • 16
    • 84857311721 scopus 로고    scopus 로고
    • Osteocyte RANKL: New insights into the control of bone remodeling
    • Xiong J, O'Brien CA. Osteocyte RANKL: new insights into the control of bone remodeling. J. Bone Miner. Res. 27(3), 499-505 (2012).
    • (2012) J. Bone Miner. Res. , vol.27 , Issue.3 , pp. 499-505
    • Xiong, J.1    O'Brien, C.A.2
  • 17
    • 84867544854 scopus 로고    scopus 로고
    • Immunolocalization of sclerostin synthesized by osteocytes in relation to bone remodeling in the interradicular septa of ovariectomized rats
    • Guo Y, Li M, Zhusheng L et al. Immunolocalization of sclerostin synthesized by osteocytes in relation to bone remodeling in the interradicular septa of ovariectomized rats. J. Electron. Microsc. (Tokyo) 61(5), 309-320 (2012).
    • (2012) J. Electron. Microsc. (Tokyo) , vol.61 , Issue.5 , pp. 309-320
    • Guo, Y.1    Li, M.2    Zhusheng, L.3
  • 18
    • 84865446399 scopus 로고    scopus 로고
    • Receptor activator of nuclear factor kB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss
    • Onal M, Xiong J, Chen X et al. Receptor activator of nuclear factor kB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J. Biol. Chem. 287(35), 29851-29860 (2012).
    • (2012) J. Biol. Chem. , vol.287 , Issue.35 , pp. 29851-29860
    • Onal, M.1    Xiong, J.2    Chen, X.3
  • 19
    • 0033398996 scopus 로고    scopus 로고
    • Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kB (RANK) receptors
    • Arai F, Miyamoto T, Ohneda O et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kB (RANK) receptors. J. Exp. Med. 190 (12), 1741-1754 (1999).
    • (1999) J. Exp. Med. , vol.190 , Issue.12 , pp. 1741-1754
    • Arai, F.1    Miyamoto, T.2    Ohneda, O.3
  • 20
    • 0035043292 scopus 로고    scopus 로고
    • Tumor necrosis factor-a cooperates with receptor activator of nuclear factor kB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture
    • Komine M, Kukita A, Kukita T, Ogata Y, Hotokebuchi T, Kohashi O. Tumor necrosis factor-a cooperates with receptor activator of nuclear factor kB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone 28(5), 474-483 (2001).
    • (2001) Bone , vol.28 , Issue.5 , pp. 474-483
    • Komine, M.1    Kukita, A.2    Kukita, T.3    Ogata, Y.4    Hotokebuchi, T.5    Kohashi, O.6
  • 21
    • 84858007236 scopus 로고    scopus 로고
    • Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
    • Maeda K, Kobayashi Y, Udagawa N et al. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 18(3), 405-412 (2012).
    • (2012) Nat. Med. , vol.18 , Issue.3 , pp. 405-412
    • Maeda, K.1    Kobayashi, Y.2    Udagawa, N.3
  • 22
    • 33947583822 scopus 로고    scopus 로고
    • Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems
    • Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7(4), 292-304 (2007).
    • (2007) Nat. Rev. Immunol. , vol.7 , Issue.4 , pp. 292-304
    • Takayanagi, H.1
  • 23
    • 6544270833 scopus 로고    scopus 로고
    • Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-defcient mice
    • Naito A, Azuma S, Tanaka S et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-defcient mice. Genes Cells 4(6), 353-362 (1999).
    • (1999) Genes Cells , vol.4 , Issue.6 , pp. 353-362
    • Naito, A.1    Azuma, S.2    Tanaka, S.3
  • 24
    • 34347356549 scopus 로고    scopus 로고
    • Eos MITF, and PU.1 recruit corepressors to osteoclast-specifc genes in committed myeloid progenitors
    • Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U, Ostrowski MC. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specifc genes in committed myeloid progenitors. Mol. Cell. Biol. 27(11), 4018-4027 (2007).
    • (2007) Mol. Cell. Biol. , vol.27 , Issue.11 , pp. 4018-4027
    • Hu, R.1    Sharma, S.M.2    Bronisz, A.3    Srinivasan, R.4    Sankar, U.5    Ostrowski, M.C.6
  • 25
    • 70349100754 scopus 로고    scopus 로고
    • 2+-NFATc1 signaling is an essential axis of osteoclast differentiation
    • 2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231(1), 241-256 (2009).
    • (2009) Immunol. Rev. , vol.231 , Issue.1 , pp. 241-256
    • Negishi-Koga, T.1    Takayanagi, H.2
  • 26
    • 70450207475 scopus 로고    scopus 로고
    • A unique domain in RANK is required for Gab2 and PLCg2 binding to establish osteoclastogenic signals
    • Taguchi Y, Gohda J, Koga T, Takayanagi H, Inoue J. A unique domain in RANK is required for Gab2 and PLCg2 binding to establish osteoclastogenic signals. Genes Cells 14(11), 1331-1345 (2009).
    • (2009) Genes Cells , vol.14 , Issue.11 , pp. 1331-1345
    • Taguchi, Y.1    Gohda, J.2    Koga, T.3    Takayanagi, H.4    Inoue, J.5
  • 27
    • 33750597150 scopus 로고    scopus 로고
    • PLCg2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2
    • Mao D, Epple H, Uthgenannt B, Novack DV, Faccio R. PLCg2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116(11), 2869-2879 (2006).
    • (2006) J. Clin. Invest. , vol.116 , Issue.11 , pp. 2869-2879
    • Mao, D.1    Epple, H.2    Uthgenannt, B.3    Novack, D.V.4    Faccio, R.5
  • 29
    • 5444229284 scopus 로고    scopus 로고
    • RANKL-induced DC-STAMP is essential for osteoclastogenesis
    • Kukita T, Wada N, Kukita A et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J. Exp. Med. 200(7), 941-946 (2004).
    • (2004) J. Exp. Med. , vol.200 , Issue.7 , pp. 941-946
    • Kukita, T.1    Wada, N.2    Kukita, A.3
  • 30
    • 23744459835 scopus 로고    scopus 로고
    • DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells
    • Yagi M, Miyamoto T, Sawatani Y et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202(3), 345-351 (2005).
    • (2005) J. Exp. Med. , vol.202 , Issue.3 , pp. 345-351
    • Yagi, M.1    Miyamoto, T.2    Sawatani, Y.3
  • 31
    • 12744269233 scopus 로고    scopus 로고
    • Role of the proto-oncogene Pokemon in cellular transformation and ARF repression
    • Maeda T, Hobbs RM, Merghoub T et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433(7023), 278-285 (2005).
    • (2005) Nature , vol.433 , Issue.7023 , pp. 278-285
    • Maeda, T.1    Hobbs, R.M.2    Merghoub, T.3
  • 32
    • 34248580502 scopus 로고    scopus 로고
    • Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF
    • Maeda T, Merghoub T, Hobbs RM et al. Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science 316(5826), 860-866 (2007).
    • (2007) Science , vol.316 , Issue.5826 , pp. 860-866
    • Maeda, T.1    Merghoub, T.2    Hobbs, R.M.3
  • 33
    • 70350061670 scopus 로고    scopus 로고
    • LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis
    • Maeda T, Ito K, Merghoub T et al. LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev. Cell 17(4), 527-540 (2009).
    • (2009) Dev. Cell , vol.17 , Issue.4 , pp. 527-540
    • Maeda, T.1    Ito, K.2    Merghoub, T.3
  • 34
    • 79960004649 scopus 로고    scopus 로고
    • The LRF transcription factor regulates mature B cell development and the germinal center response in mice
    • Sakurai N, Maeda M, Lee SU et al. The LRF transcription factor regulates mature B cell development and the germinal center response in mice. J. Clin. Invest. 121(7), 2583-2598 (2011).
    • (2011) J. Clin. Invest. , vol.121 , Issue.7 , pp. 2583-2598
    • Sakurai, N.1    Maeda, M.2    Lee, S.U.3
  • 35
    • 0033568579 scopus 로고    scopus 로고
    • Osteoclast-derived zinc fnger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis
    • Kukita A, Kukita T. Ouchida M et al. Osteoclast-derived zinc fnger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94(6) 1987-1997 (1999).
    • (1999) Blood , vol.94 , Issue.6 , pp. 1987-1997
    • Kukita, A.1    Kukita, T.2    Ouchida, M.3
  • 36
    • 80052331060 scopus 로고    scopus 로고
    • The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo
    • Kukita A, Kukita T, Nagata K et al. The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo. Arthritis Rheum. 63(9), 2744-2754 (2011).
    • (2011) Arthritis Rheum. , vol.63 , Issue.9 , pp. 2744-2754
    • Kukita, A.1    Kukita, T.2    Nagata, K.3
  • 37
    • 84857130450 scopus 로고    scopus 로고
    • Stage-specifc functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development
    • Tsuji-Takechi K, Negishi-Koga T, Sumiya E et al. Stage-specifc functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development. Proc. Natl Acad. Sci. USA 109(7), 2561-2566 (2012).
    • (2012) Proc. Natl Acad. Sci. USA , vol.109 , Issue.7 , pp. 2561-2566
    • Tsuji-Takechi, K.1    Negishi-Koga, T.2    Sumiya, E.3
  • 38
    • 83755225707 scopus 로고    scopus 로고
    • The osteoclast and its unique cytoskeleton
    • Teitelbaum SL. The osteoclast and its unique cytoskeleton. Ann. NY Acad. Sci. 1240, 14-17 (2011).
    • (2011) Ann. NY Acad. Sci. , vol.1240 , pp. 14-17
    • Teitelbaum, S.L.1
  • 40
    • 79958852901 scopus 로고    scopus 로고
    • The regulation of osteoclast function and bone resorption by small GTPases
    • Itzstein C, Coxon FP, Rogers MJ. The regulation of osteoclast function and bone resorption by small GTPases. Small GTPases 2 (3), 117-130 (2011).
    • (2011) Small GTPases , vol.2 , Issue.3 , pp. 117-130
    • Itzstein, C.1    Coxon, F.P.2    Rogers, M.J.3
  • 41
    • 21644438825 scopus 로고    scopus 로고
    • Ranking the role of RANK ligand in apoptosis
    • Bharti AC, Aggarwal BB. Ranking the role of RANK ligand in apoptosis. Apoptosis 9(6), 677-690 (2004).
    • (2004) Apoptosis , vol.9 , Issue.6 , pp. 677-690
    • Bharti, A.C.1    Aggarwal, B.B.2
  • 42
    • 13444291284 scopus 로고    scopus 로고
    • Regulation of apoptosis in osteoclasts and osteoblastic cells
    • Xing L, Boyce BF. Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem. Biophys. Res. Commun. 328(3), 709-720 (2005).
    • (2005) Biochem. Biophys. Res. Commun. , vol.328 , Issue.3 , pp. 709-720
    • Xing, L.1    Boyce, B.F.2
  • 43
    • 0033393957 scopus 로고    scopus 로고
    • TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src
    • Wong BR, Besser D, Kim N et al. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell. 4(6), 1041-1049 (1999).
    • (1999) Mol. Cell. , vol.4 , Issue.6 , pp. 1041-1049
    • Wong, B.R.1    Besser, D.2    Kim, N.3
  • 44
    • 0033888977 scopus 로고    scopus 로고
    • Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
    • Lacey DL, Tan HL, Lu J et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am. J. Pathol. 157(2), 435-448 (2000).
    • (2000) Am. J. Pathol. , vol.157 , Issue.2 , pp. 435-448
    • Lacey, D.L.1    Tan, H.L.2    Lu, J.3
  • 46
    • 46049108371 scopus 로고    scopus 로고
    • Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway
    • Chamoux E, Houde N, L'Eriger K, Roux S. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway. J. Cell. Physiol. 216(2), 536-542 (2008).
    • (2008) J. Cell. Physiol. , vol.216 , Issue.2 , pp. 536-542
    • Chamoux, E.1    Houde, N.2    L'Eriger, K.3    Roux, S.4
  • 47
    • 78649470387 scopus 로고    scopus 로고
    • Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption
    • Baud'huin M, Ruiz-Velasco C, Jego G et al. Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption. Eur. J. Cell. Biol. 90 (1), 49-57 (2011).
    • (2011) Eur. J. Cell. Biol. , vol.90 , Issue.1 , pp. 49-57
    • Baud'Huin, M.1    Ruiz-Velasco, C.2    Jego, G.3
  • 48
    • 41849089744 scopus 로고    scopus 로고
    • Heparin inhibits osteoclastic differentiation and function
    • Ariyoshi W, Takahashi T, Kanno T et al. Heparin inhibits osteoclastic differentiation and function. J. Cell. Biochem. 103(6), 1707-1717 (2008).
    • (2008) J. Cell. Biochem. , vol.103 , Issue.6 , pp. 1707-1717
    • Ariyoshi, W.1    Takahashi, T.2    Kanno, T.3
  • 49
    • 34347220458 scopus 로고    scopus 로고
    • Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity
    • Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Bone 41(2), 165-174 (2007).
    • (2007) Bone , vol.41 , Issue.2 , pp. 165-174
    • Irie, A.1    Takami, M.2    Kubo, H.3    Sekino-Suzuki, N.4    Kasahara, K.5    Sanai, Y.6
  • 50
    • 58349111534 scopus 로고    scopus 로고
    • Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma
    • Lamoureux F, Picarda G, Garrigue-Antar L et al. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res. 69(2), 526-536 (2009).
    • (2009) Cancer Res. , vol.69 , Issue.2 , pp. 526-536
    • Lamoureux, F.1    Picarda, G.2    Garrigue-Antar, L.3
  • 52
    • 78649320264 scopus 로고    scopus 로고
    • Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: Stimulation of epithelial to mesenchymal transition (EMT)
    • Martin FT, Dwyer RM, Kelly J et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res. Treat. 124(2), 317-326 (2010).
    • (2010) Breast Cancer Res. Treat. , vol.124 , Issue.2 , pp. 317-326
    • Martin, F.T.1    Dwyer, R.M.2    Kelly, J.3
  • 53
    • 81255205399 scopus 로고    scopus 로고
    • Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
    • Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20(5), 576-590 (2011).
    • (2011) Cancer Cell , vol.20 , Issue.5 , pp. 576-590
    • Labelle, M.1    Begum, S.2    Hynes, R.O.3
  • 54
    • 84867115486 scopus 로고    scopus 로고
    • Microenvironmental regulation of epithelial-mesenchymal transitions in cancer
    • Gao D, Vahdat LT, Wong S, Chang JC, Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res. 72(19), 4883-4889 (2012).
    • (2012) Cancer Res. , vol.72 , Issue.19 , pp. 4883-4889
    • Gao, D.1    Vahdat, L.T.2    Wong, S.3    Chang, J.C.4    Mittal, V.5
  • 55
    • 57349101056 scopus 로고    scopus 로고
    • Osteotropic cancers: From primary tumor to bone
    • Buijs JT, van der Pluijm G. Osteotropic cancers: from primary tumor to bone. Cancer Lett. 273(2), 177-193 (2009).
    • (2009) Cancer Lett. , vol.273 , Issue.2 , pp. 177-193
    • Buijs, J.T.1    Van Der Pluijm, G.2
  • 56
    • 79952193038 scopus 로고    scopus 로고
    • Tu m o u r-infltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
    • Tan W, Zhang W, Strasner A et al. Tu m o u r-infltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470(7335), 548-553 (2011).
    • (2011) Nature , vol.470 , Issue.7335 , pp. 548-553
    • Tan, W.1    Zhang, W.2    Strasner, A.3
  • 58
    • 84863569576 scopus 로고    scopus 로고
    • CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis
    • Lee JH, Kim HN, Kim KO et al. CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis. Cancer Res. 72(13), 3175-3186.
    • Cancer Res. , vol.72 , Issue.13 , pp. 3175-3186
    • Lee, J.H.1    Kim, H.N.2    Kim, K.O.3
  • 59
    • 33750073849 scopus 로고    scopus 로고
    • RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4
    • Nakamura ES, Koizumi K, Kobayashi M et al. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin. Exp. Metastasis 23(1), 9-18 (2006).
    • (2006) Clin. Exp. Metastasis , vol.23 , Issue.1 , pp. 9-18
    • Nakamura, E.S.1    Koizumi, K.2    Kobayashi, M.3
  • 60
    • 33645453481 scopus 로고    scopus 로고
    • Regulation of cancer cell migration and bone metastasis by RANKL
    • Jones DH, Nakashima T, Sanchez OH et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440(7084), 692-696 (2006).
    • (2006) Nature , vol.440 , Issue.7084 , pp. 692-696
    • Jones, D.H.1    Nakashima, T.2    Sanchez, O.H.3
  • 62
    • 84858199187 scopus 로고    scopus 로고
    • Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition
    • Gao D, Joshi N, Choi H et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 72(6), 1384-1394 (2012).
    • (2012) Cancer Res. , vol.72 , Issue.6 , pp. 1384-1394
    • Gao, D.1    Joshi, N.2    Choi, H.3
  • 63
    • 78650304106 scopus 로고    scopus 로고
    • Advances in the biology of bone metastasis: How the skeleton affects tumor behavior
    • Sterling JA, Edwards JR, Martin TJ, Mundy GR. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone 48(1), 6-15 (2011).
    • (2011) Bone , vol.48 , Issue.1 , pp. 6-15
    • Sterling, J.A.1    Edwards, J.R.2    Martin, T.J.3    Mundy, G.R.4
  • 64
    • 4644261592 scopus 로고    scopus 로고
    • Mechanisms of bone metastasis
    • Roodman GD. Mechanisms of bone metastasis. N. Engl. J. Med. 350(16), 1655-1664 (2004).
    • (2004) N. Engl. J. Med. , vol.350 , Issue.16 , pp. 1655-1664
    • Roodman, G.D.1
  • 65
    • 84855999380 scopus 로고    scopus 로고
    • Molecular pathways: Osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis
    • Dougall WC. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin. Cancer Res. 18(2), 326-335 (2011).
    • (2011) Clin. Cancer Res. , vol.18 , Issue.2 , pp. 326-335
    • Dougall, W.C.1
  • 66
    • 84865116604 scopus 로고    scopus 로고
    • Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases
    • Hiraga T, Myoui A, Hashimoto N et al. Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases. Cancer Res. 72(16), 4238-4249 (2012).
    • (2012) Cancer Res. , vol.72 , Issue.16 , pp. 4238-4249
    • Hiraga, T.1    Myoui, A.2    Hashimoto, N.3
  • 67
    • 0034730327 scopus 로고    scopus 로고
    • The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
    • Fata JE, Kong YY, Li J et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103(1), 41-50 (2000).
    • (2000) Cell , vol.103 , Issue.1 , pp. 41-50
    • Fata, J.E.1    Kong, Y.Y.2    Li, J.3
  • 68
    • 84860332532 scopus 로고    scopus 로고
    • From the ranks of mammary progesterone mediators, RANKL takes the spotlight
    • Fernandez-Valdivia R, Lydon JP. From the ranks of mammary progesterone mediators, RANKL takes the spotlight. Mol. Cell. Endocrinol. 357(1-2), 91-100 (2009).
    • (2009) Mol. Cell. Endocrinol. , vol.357 , Issue.1-2 , pp. 91-100
    • Fernandez-Valdivia, R.1    Lydon, J.P.2
  • 69
    • 79955089567 scopus 로고    scopus 로고
    • Receptor activator of NF-kB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit
    • Duheron V, Hess E, Duval M et al. Receptor activator of NF-kB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. Proc. Natl Acad. Sci. USA 108(13), 5342-5347 (2011).
    • (2011) Proc. Natl Acad. Sci. USA , vol.108 , Issue.13 , pp. 5342-5347
    • Duheron, V.1    Hess, E.2    Duval, M.3
  • 70
    • 78049264846 scopus 로고    scopus 로고
    • Synthesis of artifcial lymphoid tissue with immunological function
    • Kobayashi Y, Watanabe T. Synthesis of artifcial lymphoid tissue with immunological function. Trends Immunol. 31(11), 422-428 (2010).
    • (2010) Trends Immunol. , vol.31 , Issue.11 , pp. 422-428
    • Kobayashi, Y.1    Watanabe, T.2
  • 71
    • 84874257342 scopus 로고    scopus 로고
    • Emerging functions of RANKL in lymphoid tissues
    • Mueller CG, Hess E. Emerging functions of RANKL in lymphoid tissues. Front. Immunol. 3, 261 (2012).
    • (2012) Front. Immunol. , vol.3 , Issue.261
    • Mueller, C.G.1    Hess, E.2
  • 72
    • 77950491661 scopus 로고    scopus 로고
    • RANKL is necessary and suffcient to initiate development of antigen-sampling M cells in the intestinal epithelium
    • Knoop KA, Kumar N, Butler BR et al. RANKL is necessary and suffcient to initiate development of antigen-sampling M cells in the intestinal epithelium. J. Immunol. 183(9), 5738-5747 (2009).
    • (2009) J. Immunol. , vol.183 , Issue.9 , pp. 5738-5747
    • Knoop, K.A.1    Kumar, N.2    Butler, B.R.3
  • 73
    • 84864147310 scopus 로고    scopus 로고
    • The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells
    • Kanaya T, Hase K, Takahashi D et al. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat. Immunol. 13(8), 729-736 (2012).
    • (2012) Nat. Immunol. , vol.13 , Issue.8 , pp. 729-736
    • Kanaya, T.1    Hase, K.2    Takahashi, D.3
  • 74
    • 51349092893 scopus 로고    scopus 로고
    • The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator
    • Hikosaka Y, Nitta T, Ohigashi I et al. The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity 29(3), 438-450 (2008).
    • (2008) Immunity , vol.29 , Issue.3 , pp. 438-450
    • Hikosaka, Y.1    Nitta, T.2    Ohigashi, I.3
  • 75
    • 51349111243 scopus 로고    scopus 로고
    • The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance
    • Akiyama T, Shimo Y, Yanai H et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29(3), 423-437 (2008).
    • (2008) Immunity , vol.29 , Issue.3 , pp. 423-437
    • Akiyama, T.1    Shimo, Y.2    Yanai, H.3
  • 76
    • 78650671134 scopus 로고    scopus 로고
    • Expression pattern of receptor activator of NFkB (RANK) in a series of primary solid tumors and related bone metastases
    • Santini D, Perrone G, Roato I et al. Expression pattern of receptor activator of NFkB (RANK) in a series of primary solid tumors and related bone metastases. J. Cell. Physiol. 226(3), 780-784 (2010).
    • (2010) J. Cell. Physiol. , vol.226 , Issue.3 , pp. 780-784
    • Santini, D.1    Perrone, G.2    Roato, I.3
  • 77
    • 79955772442 scopus 로고    scopus 로고
    • Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients
    • Santini D, Schiavon G, Vincenzi B et al. Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. PLoS One 6(4), e19234 (2011).
    • (2011) PLoS One , vol.6 , Issue.4
    • Santini, D.1    Schiavon, G.2    Vincenzi, B.3
  • 78
    • 33745821237 scopus 로고    scopus 로고
    • Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation
    • Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, Rabbani SA. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107(2), 289-298 (2006).
    • (2006) Cancer , vol.107 , Issue.2 , pp. 289-298
    • Chen, G.1    Sircar, K.2    Aprikian, A.3    Potti, A.4    Goltzman, D.5    Rabbani, S.A.6
  • 79
    • 67650924224 scopus 로고    scopus 로고
    • Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas
    • Mikami S, Katsube K, Oya M et al. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. J. Pathol. 218(4), 530-539 (2009).
    • (2009) J. Pathol. , vol.218 , Issue.4 , pp. 530-539
    • Mikami, S.1    Katsube, K.2    Oya, M.3
  • 80
    • 84874883241 scopus 로고    scopus 로고
    • Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer
    • Peng X, Guo W, Ren T et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. PLoS One 8(3), e58361 (2013).
    • (2013) PLoS One , vol.8 , Issue.3
    • Peng, X.1    Guo, W.2    Ren, T.3
  • 81
    • 33947646303 scopus 로고    scopus 로고
    • Human osteosarcoma cells express functional receptor activator of nuclear factor-kB
    • Mori K, Le Goff B, Berreur M et al. Human osteosarcoma cells express functional receptor activator of nuclear factor-kB. J. Pathol. 211(5), 555-562 (2007).
    • (2007) J. Pathol. , vol.211 , Issue.5 , pp. 555-562
    • Mori, K.1    Le Goff, B.2    Berreur, M.3
  • 82
    • 84861213409 scopus 로고    scopus 로고
    • Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells
    • Beristain AG, Narala SR, Di Grappa MA, Khokha R. Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. J. Cell. Sci. 125(Pt 4), 943-955 (2011).
    • (2011) J. Cell. Sci. , vol.125 , Issue.PART 4 , pp. 943-955
    • Beristain, A.G.1    Narala, S.R.2    Di Grappa, M.A.3    Khokha, R.4
  • 83
    • 79952764688 scopus 로고    scopus 로고
    • RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells
    • Kupas V, Weishaupt C, Siepmann D et al. RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells. J. Invest. Dermatol. 131(4), 944-955 (2011).
    • (2011) J. Invest. Dermatol. , vol.131 , Issue.4 , pp. 944-955
    • Kupas, V.1    Weishaupt, C.2    Siepmann, D.3
  • 84
    • 0037389602 scopus 로고    scopus 로고
    • Expression of receptor activator of nuclear factor kB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma
    • Heider U, Langelotz C, Jakob C et al. Expression of receptor activator of nuclear factor kB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma. Clin. Cancer Res. 9(4), 1436-1440 (2003).
    • (2003) Clin. Cancer Res. , vol.9 , Issue.4 , pp. 1436-1440
    • Heider, U.1    Langelotz, C.2    Jakob, C.3
  • 85
    • 0037443533 scopus 로고    scopus 로고
    • RANK ligand and osteoprotegerin in myeloma bone disease
    • Sezer O, Heider U, Zavrski I, Kuhne CA, Hofbauer LC. RANK ligand and osteoprotegerin in myeloma bone disease. Blood 101(6), 2094-2098 (2003).
    • (2003) Blood , vol.101 , Issue.6 , pp. 2094-2098
    • Sezer, O.1    Heider, U.2    Zavrski, I.3    Kuhne, C.A.4    Hofbauer, L.C.5
  • 86
    • 0033305673 scopus 로고    scopus 로고
    • Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast
    • Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J. Clin. Endocrinol. Metab. 84(12), 4559-4565 (1999).
    • (1999) J. Clin. Endocrinol. Metab. , vol.84 , Issue.12 , pp. 4559-4565
    • Hofseth, L.J.1    Raafat, A.M.2    Osuch, J.R.3    Pathak, D.R.4    Slomski, C.A.5    Haslam, S.Z.6
  • 87
    • 78149284013 scopus 로고    scopus 로고
    • Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
    • Schramek D, Leibbrandt A, Sigl V et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468(7320), 98-102 (2010).
    • (2010) Nature , vol.468 , Issue.7320 , pp. 98-102
    • Schramek, D.1    Leibbrandt, A.2    Sigl, V.3
  • 88
    • 78149284767 scopus 로고    scopus 로고
    • RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
    • Gonzalez-Suarez E, Jacob A P, Jones J et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468(7320), 103-107 (2010).
    • (2010) Nature , vol.468 , Issue.7320 , pp. 103-107
    • Gonzalez-Suarez, E.1    Jacob, A.P.2    Jones, J.3
  • 89
    • 33845543666 scopus 로고    scopus 로고
    • Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
    • Loser K, Mehling A, Loeser S et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12(12), 1372-1379 (2006).
    • (2006) Nat. Med. , vol.12 , Issue.12 , pp. 1372-1379
    • Loser, K.1    Mehling, A.2    Loeser, S.3
  • 90
    • 73849123602 scopus 로고    scopus 로고
    • Expansion of antigen-specifc regulatory T cells with the topical vitamin D analog calcipotriol
    • Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP. Expansion of antigen-specifc regulatory T cells with the topical vitamin D analog calcipotriol. J. Immunol. 182(10), 6071-6078 (2009).
    • (2009) J. Immunol. , vol.182 , Issue.10 , pp. 6071-6078
    • Ghoreishi, M.1    Bach, P.2    Obst, J.3    Komba, M.4    Fleet, J.C.5    Dutz, J.P.6
  • 91
    • 0035861314 scopus 로고    scopus 로고
    • IKKa provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
    • Cao Y, Bonizzi G, Seagroves TN et al. IKKa provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107(6), 763-775 (2001).
    • (2001) Cell , vol.107 , Issue.6 , pp. 763-775
    • Cao, Y.1    Bonizzi, G.2    Seagroves, T.N.3
  • 92
    • 31344455071 scopus 로고    scopus 로고
    • Receptor activator of NF-kB ligand regulates the proliferation of mammary epithelial cells via Id2
    • Kim NS, Kim HJ, Koo BK et al. Receptor activator of NF-kB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol. Cell. Biol. 26(3), 1002-1013 (2006).
    • (2006) Mol. Cell. Biol. , vol.26 , Issue.3 , pp. 1002-1013
    • Kim, N.S.1    Kim, H.J.2    Koo, B.K.3
  • 93
    • 83255186733 scopus 로고    scopus 로고
    • Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling
    • Kim NS, Kim HT, Kwon MC et al. Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling. Mol. Cell. Biol. 31(23), 4775-4788 (2011).
    • (2011) Mol. Cell. Biol. , vol.31 , Issue.23 , pp. 4775-4788
    • Kim, N.S.1    Kim, H.T.2    Kwon, M.C.3
  • 94
    • 77951214454 scopus 로고    scopus 로고
    • The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells
    • Zielinski AJ, Fong S, Allison J et al. The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells. Int. J. Cancer 126(10), 2490-2496 (2010).
    • (2010) Int. J. Cancer , vol.126 , Issue.10 , pp. 2490-2496
    • Zielinski, A.J.1    Fong, S.2    Allison, J.3
  • 95
    • 51049121618 scopus 로고    scopus 로고
    • RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
    • Miller RE, Roudier M, Jones J, Armstrong A, Canon J, Dougall WC. RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis. Mol. Cancer Ther. 7(7), 2160-2169 (2008).
    • (2008) Mol. Cancer Ther. , vol.7 , Issue.7 , pp. 2160-2169
    • Miller, R.E.1    Roudier, M.2    Jones, J.3    Armstrong, A.4    Canon, J.5    Dougall, W.C.6
  • 96
    • 80755168375 scopus 로고    scopus 로고
    • The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells
    • Shin M, Matsuo K, Tada T et al. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis 32(11), 1634-1640 (2011).
    • (2011) Carcinogenesis , vol.32 , Issue.11 , pp. 1634-1640
    • Shin, M.1    Matsuo, K.2    Tada, T.3
  • 97
    • 67649311599 scopus 로고    scopus 로고
    • Latent bone metastasis in breast cancer tied to Src-dependent survival signals
    • Zhang XH, Wang Q, Gerald W et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16(1), 67-78 (2009).
    • (2009) Cancer Cell , vol.16 , Issue.1 , pp. 67-78
    • Zhang, X.H.1    Wang, Q.2    Gerald, W.3
  • 98
    • 49149114127 scopus 로고    scopus 로고
    • Receptor activator of NF-kB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
    • Odero-Marah VA, Wang R, Chu G et al. Receptor activator of NF-kB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res. 18(8), 858-870 (2008).
    • (2008) Cell Res. , vol.18 , Issue.8 , pp. 858-870
    • Odero-Marah, V.A.1    Wang, R.2    Chu, G.3
  • 99
    • 77954355093 scopus 로고    scopus 로고
    • Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration
    • Sabbota AL, Kim HR, Zhe X, Fridman R, Bonfl RD, Cher ML. Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration. Cancer Res. 70(13), 5558-5566 (2010).
    • (2010) Cancer Res. , vol.70 , Issue.13 , pp. 5558-5566
    • Sabbota, A.L.1    Kim, H.R.2    Zhe, X.3    Fridman, R.4    Bonfl, R.D.5    Cher, M.L.6
  • 100
    • 84861854171 scopus 로고    scopus 로고
    • RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis
    • Palafox M, Ferrer I, Pellegrini P et al. RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. Cancer Res. 72(11), 2879-2888 (2012).
    • (2012) Cancer Res. , vol.72 , Issue.11 , pp. 2879-2888
    • Palafox, M.1    Ferrer, I.2    Pellegrini, P.3
  • 101
    • 34247274248 scopus 로고    scopus 로고
    • Nuclear cytokine-activated IKKa controls prostate cancer metastasis by repressing Maspin
    • Luo JL, Tan W, Ricono JM et al. Nuclear cytokine-activated IKKa controls prostate cancer metastasis by repressing Maspin. Nature 446(7136), 690-694 (2007).
    • (2007) Nature , vol.446 , Issue.7136 , pp. 690-694
    • Luo, J.L.1    Tan, W.2    Ricono, J.M.3
  • 102
    • 79960129686 scopus 로고    scopus 로고
    • Maspin, the molecular bridge between the plasminogen activator system and b1 integrin that facilitates cell adhesion
    • Endsley MP, Hu Y, Deng Y et al. Maspin, the molecular bridge between the plasminogen activator system and b1 integrin that facilitates cell adhesion. J. Biol. Chem. 286(28), 24599-24607 (2011).
    • (2011) J. Biol. Chem. , vol.286 , Issue.28 , pp. 24599-24607
    • Endsley, M.P.1    Hu, Y.2    Deng, Y.3
  • 103
    • 37449004858 scopus 로고    scopus 로고
    • RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes
    • Armstrong A P, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate 68(1), 92-104 (2008).
    • (2008) Prostate , vol.68 , Issue.1 , pp. 92-104
    • Armstrong, A.P.1    Miller, R.E.2    Jones, J.C.3    Zhang, J.4    Keller, E.T.5    Dougall, W.C.6
  • 104
    • 66449121642 scopus 로고    scopus 로고
    • CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
    • Ma X, Norsworthy K, Kundu N et al. CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Mol. Cancer Ther. 8(3), 490-498 (2009).
    • (2009) Mol. Cancer Ther. , vol.8 , Issue.3 , pp. 490-498
    • Ma, X.1    Norsworthy, K.2    Kundu, N.3
  • 105
    • 84868117017 scopus 로고    scopus 로고
    • Characterization and identifcation of subpopulations of mononuclear preosteoclasts induced by TNF-a in combination with TGF-b in rats
    • Matsubara R, Kukita T, Ichigi Y et al. Characterization and identifcation of subpopulations of mononuclear preosteoclasts induced by TNF-a in combination with TGF-b in rats. PLoS One 7(10), e47930 (2012).
    • (2012) PLoS One , vol.7 , Issue.10
    • Matsubara, R.1    Kukita, T.2    Ichigi, Y.3
  • 106
    • 0842325055 scopus 로고    scopus 로고
    • Direct stimulation of osteoclastogenesis by MIP-1a: Evidence obtained from studies using RAW264 cell clone highly responsive to RANKL
    • Watanabe T, Kukita T, Kukita A et al. Direct stimulation of osteoclastogenesis by MIP-1a: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J. Endocrinol. 180(1), 193-201 (2004).
    • (2004) J. Endocrinol. , vol.180 , Issue.1 , pp. 193-201
    • Watanabe, T.1    Kukita, T.2    Kukita, A.3
  • 107
    • 84865171804 scopus 로고    scopus 로고
    • CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
    • Dairaghi DJ, Oyajobi BO, Gupta A et al. CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. Blood 120(7), 1449-1457 (2012).
    • (2012) Blood , vol.120 , Issue.7 , pp. 1449-1457
    • Dairaghi, D.J.1    Oyajobi, B.O.2    Gupta, A.3
  • 108
    • 4344612243 scopus 로고    scopus 로고
    • NF-kB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
    • Huber MA, Azoitei N, Baumann B et al. NF-kB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114 (4), 569-581 (2004).
    • (2004) J. Clin. Invest. , vol.114 , Issue.4 , pp. 569-581
    • Huber, M.A.1    Azoitei, N.2    Baumann, B.3
  • 109
    • 84869153585 scopus 로고    scopus 로고
    • Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion
    • Tahoun A, Mahajan S, Paxton E et al. Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion. Cell Host Microbe 12(5), 645-656 (2012).
    • (2012) Cell Host Microbe , vol.12 , Issue.5 , pp. 645-656
    • Tahoun, A.1    Mahajan, S.2    Paxton, E.3
  • 110
    • 79551592979 scopus 로고    scopus 로고
    • New approaches to the treatment of osteoporosis
    • Silva BC, Bilezikian JP. New approaches to the treatment of osteoporosis. Annu. Rev. Med. 62, 307-322 (2011).
    • (2011) Annu. Rev. Med. , vol.62 , pp. 307-322
    • Silva, B.C.1    Bilezikian, J.P.2
  • 111
    • 69049083492 scopus 로고    scopus 로고
    • Denosumab for prevention of fractures in postmenopausal women with osteoporosis
    • Cummings SR, San Martin J, McClung MR et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 361(8), 756-765 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , Issue.8 , pp. 756-765
    • Cummings, S.R.1    San Martin, J.2    McClung, M.R.3
  • 112
    • 3342982829 scopus 로고    scopus 로고
    • A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women
    • Bekker PJ, Holloway DL, Rasmussen AS et al. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J. Bone. Miner. Res. 19(7), 1059-1066 (2004).
    • (2004) J. Bone. Miner. Res. , vol.19 , Issue.7 , pp. 1059-1066
    • Bekker, P.J.1    Holloway, D.L.2    Rasmussen, A.S.3
  • 113
    • 84872283943 scopus 로고    scopus 로고
    • Management of bone metastases in refractory prostate cancer-role of denosumab
    • Paller CJ, Carducci MA, Philips GK. Management of bone metastases in refractory prostate cancer-role of denosumab. Clin. Interv. Aging 7, 363-372 (2012).
    • (2012) Clin. Interv. Aging , vol.7 , pp. 363-372
    • Paller, C.J.1    Carducci, M.A.2    Philips, G.K.3
  • 114
    • 69049105440 scopus 로고    scopus 로고
    • Denosumab in men receiving androgen-deprivation therapy for prostate cancer
    • Smith MR, Egerdie B, Hernandez Toriz N et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N. Engl. J. Med. 361(8), 745-755 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , Issue.8 , pp. 745-755
    • Smith, M.R.1    Egerdie, B.2    Hernandez Toriz, N.3
  • 115
    • 84855516339 scopus 로고    scopus 로고
    • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomised, placebo-controlled trial
    • Smith MR, Saad F, Coleman R et al. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet 379(9810), 39-46 (2012).
    • (2012) Lancet , vol.379 , Issue.9810 , pp. 39-46
    • Smith, M.R.1    Saad, F.2    Coleman, R.3
  • 116
    • 54449084015 scopus 로고    scopus 로고
    • Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer
    • Ellis GK, Bone HG, Chlebowski R et al. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J. Clin. Oncol. 26(30), 4875-4882 (2008).
    • (2008) J. Clin. Oncol. , vol.26 , Issue.30 , pp. 4875-4882
    • Ellis, G.K.1    Bone, H.G.2    Chlebowski, R.3
  • 117
    • 79551568488 scopus 로고    scopus 로고
    • Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study
    • Stopeck AT, Lipton A, Body JJ et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J. Clin. Oncol. 28(35), 5132-5139 (2010).
    • (2010) J. Clin. Oncol. , vol.28 , Issue.35 , pp. 5132-5139
    • Stopeck, A.T.1    Lipton, A.2    Body, J.J.3
  • 118
    • 79952761418 scopus 로고    scopus 로고
    • Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma
    • Henry DH, Costa L, Goldwasser F et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J. Clin. Oncol. 29(9), 1125-1132 (2011).
    • (2011) J. Clin. Oncol. , vol.29 , Issue.9 , pp. 1125-1132
    • Henry, D.H.1    Costa, L.2    Goldwasser, F.3
  • 119
    • 58149198581 scopus 로고    scopus 로고
    • Extended effcacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy
    • Lipton A, Steger GG, Figueroa J et al. Extended effcacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy. Clin. Cancer Res. 14(20), 6690-6696 (2008).
    • (2008) Clin. Cancer Res. , vol.14 , Issue.20 , pp. 6690-6696
    • Lipton, A.1    Steger, G.G.2    Figueroa, J.3
  • 120
    • 35348897212 scopus 로고    scopus 로고
    • Randomized active-controlled Phase II study of denosumab effcacy and safety in patients with breast cancer-related bone metastases
    • Lipton A, Steger GG, Figueroa J et al. Randomized active-controlled Phase II study of denosumab effcacy and safety in patients with breast cancer-related bone metastases. J. Clin. Oncol. 25(28), 4431-4437 (2007).
    • (2007) J. Clin. Oncol. , vol.25 , Issue.28 , pp. 4431-4437
    • Lipton, A.1    Steger, G.G.2    Figueroa, J.3
  • 121
    • 84863069811 scopus 로고    scopus 로고
    • Denosumab and the current status of bone-modifying drugs in breast cancer
    • Lee BL, Higgins MJ, Goss PE. Denosumab and the current status of bone-modifying drugs in breast cancer. Acta Oncol. 51(2), 157-167 (2012).
    • (2012) Acta Oncol. , vol.51 , Issue.2 , pp. 157-167
    • Lee, B.L.1    Higgins, M.J.2    Goss, P.E.3
  • 122
    • 84856088337 scopus 로고    scopus 로고
    • EMT and dissemination precede pancreatic tumor formation
    • Rhim AD, Mirek ET, Aiello NM et al. EMT and dissemination precede pancreatic tumor formation. Cell 148(1-2), 349-361 (2012).
    • (2012) Cell 148 , vol.1-2 , pp. 349-361
    • Rhim, A.D.1    Mirek, E.T.2    Aiello, N.M.3
  • 123
    • 77952095079 scopus 로고    scopus 로고
    • Osteoclasts are involved in the maintenance of dormant leukemic cells
    • Yokota A, Kimura S, Tanaka R et al. Osteoclasts are involved in the maintenance of dormant leukemic cells. Leuk. Res. 34(6), 793-799 (2010).
    • (2010) Leuk. Res. , vol.34 , Issue.6 , pp. 793-799
    • Yokota, A.1    Kimura, S.2    Tanaka, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.